Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Wilms Tumor × Isotretinoin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Neuroblastoma 40 Lung Neoplasms 4 Leukemia, Myelomonocytic, Juvenile 4 Ganglioneuroblastoma 4 Brain Neoplasms 4 Uterine Cervical Neoplasms 3 Small Cell Lung Carcinoma 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Medulloblastoma 3 Leukemia, Myeloid, Acute 3 Leukemia 3 Kidney Neoplasms 3 Head and Neck Neoplasms 3 Gliosarcoma 3 Glioma 3 Glioblastoma 3 Central Nervous System Neoplasms 3 Carcinoma, Renal Cell 3 Carcinoma, Non-Small-Cell Lung 3 Astrocytoma 3 Squamous Cell Carcinoma of Head and Neck 2 Recurrence 2 Prostatic Neoplasms 2 Oligodendroglioma 2 Neoplasms 2 Myelodysplastic Syndromes 2 Mycosis Fungoides 2 Lymphoma, Large B-Cell, Diffuse 2 HIV Infections 2 Burkitt Lymphoma 2

Interventions

Cyclophosphamide 15 Vincristine 13 Radiotherapy 10 Filgrastim 10 Etoposide 10 Doxorubicin 9 Carboplatin 9 X-Rays 8 Phantoms, Imaging 8 Granulocyte Colony-Stimulating Factor 8 Specimen Handling 7 Magnetic Resonance Spectroscopy 7 Temozolomide 6 Melphalan 6 Ifosfamide 6 Dactinomycin 6 Peripheral Blood Stem Cell Transplantation 5 Nuclear Medicine Department, Hospital 5 Irinotecan 5 Busulfan 5 Biopsy 5 sargramostim 4 Topotecan 4 Stem Cell Transplantation 4 fludarabine 3 Radiation 3 Nivolumab 3 Mesna 3 Itraconazole 3 Cisplatin 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05384821 2026-03-18

MetroWilms

Centre Oscar Lambret

Phase 1/2 Recruiting

Kidney Neoplasms, Wilms Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡